MT 7117 is at least 3 years away and may never be approved. They are slowly recruiting their 150-patient goal for their current trial. Let's estimate the last patient enrolls in Sept 2024, which pushes us to Nov 2025 for trial completion (14.5 months). Add 6 months of data analysis and then 1 year for FDA review. Late 2027 or early 2028, if ever. 100 MGs didn't work. 300 MGs didn't work. Will 200 MGs be the magic number?
Clinuvel's issue isn't competition. Clinuvel's issue is Clinuvel!
MT 7117 is at least 3 years away and may never be approved. They...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.63 |
Change
0.120(0.89%) |
Mkt cap ! $682.3M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.77 | $13.43 | $581.2K | 42.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 248 | $13.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.64 | 1 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |